Portasystemic shunting remains the procedure of choice for control of variceal hemorrhage

B. A. Levine, H. V. Gaskill, Kenneth R Sirinek

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We reviewed 108 patients (50% Child's C) who had been admitted with acutely bleeding esophageal varices to compare the efficacy of operative (portasystemic shunt) therapy with the reported efficacy of sclerotherapy. In the patients with shunts the early mortality (preoperative plus operative) was 13% and late mortality was 23%. Survival at five years was 50%. Recurrent variceal bleeding was seen in 4% of the patients. Procedure-related mortality and variceal rebleeding rates for the shunt group were respectively 50% and 8% of that reported for slcerotherapy. Variceal rebleeding in the sclerotherapy group required approximately 7 units of blood per episode. We concluded that immediate attempts at control of hemorrhage followed by portasystemic shunting remains the therapy of choice for these patients.

Original languageEnglish (US)
Pages (from-to)296-300
Number of pages5
JournalArchives of Surgery
Volume120
Issue number3
StatePublished - 1985

Fingerprint

Hemorrhage
Sclerotherapy
Mortality
Surgical Portasystemic Shunt
Esophageal and Gastric Varices
Survival
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Portasystemic shunting remains the procedure of choice for control of variceal hemorrhage. / Levine, B. A.; Gaskill, H. V.; Sirinek, Kenneth R.

In: Archives of Surgery, Vol. 120, No. 3, 1985, p. 296-300.

Research output: Contribution to journalArticle

@article{502dc27766fe4d11b0f7c0f60d8b30cc,
title = "Portasystemic shunting remains the procedure of choice for control of variceal hemorrhage",
abstract = "We reviewed 108 patients (50{\%} Child's C) who had been admitted with acutely bleeding esophageal varices to compare the efficacy of operative (portasystemic shunt) therapy with the reported efficacy of sclerotherapy. In the patients with shunts the early mortality (preoperative plus operative) was 13{\%} and late mortality was 23{\%}. Survival at five years was 50{\%}. Recurrent variceal bleeding was seen in 4{\%} of the patients. Procedure-related mortality and variceal rebleeding rates for the shunt group were respectively 50{\%} and 8{\%} of that reported for slcerotherapy. Variceal rebleeding in the sclerotherapy group required approximately 7 units of blood per episode. We concluded that immediate attempts at control of hemorrhage followed by portasystemic shunting remains the therapy of choice for these patients.",
author = "Levine, {B. A.} and Gaskill, {H. V.} and Sirinek, {Kenneth R}",
year = "1985",
language = "English (US)",
volume = "120",
pages = "296--300",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Portasystemic shunting remains the procedure of choice for control of variceal hemorrhage

AU - Levine, B. A.

AU - Gaskill, H. V.

AU - Sirinek, Kenneth R

PY - 1985

Y1 - 1985

N2 - We reviewed 108 patients (50% Child's C) who had been admitted with acutely bleeding esophageal varices to compare the efficacy of operative (portasystemic shunt) therapy with the reported efficacy of sclerotherapy. In the patients with shunts the early mortality (preoperative plus operative) was 13% and late mortality was 23%. Survival at five years was 50%. Recurrent variceal bleeding was seen in 4% of the patients. Procedure-related mortality and variceal rebleeding rates for the shunt group were respectively 50% and 8% of that reported for slcerotherapy. Variceal rebleeding in the sclerotherapy group required approximately 7 units of blood per episode. We concluded that immediate attempts at control of hemorrhage followed by portasystemic shunting remains the therapy of choice for these patients.

AB - We reviewed 108 patients (50% Child's C) who had been admitted with acutely bleeding esophageal varices to compare the efficacy of operative (portasystemic shunt) therapy with the reported efficacy of sclerotherapy. In the patients with shunts the early mortality (preoperative plus operative) was 13% and late mortality was 23%. Survival at five years was 50%. Recurrent variceal bleeding was seen in 4% of the patients. Procedure-related mortality and variceal rebleeding rates for the shunt group were respectively 50% and 8% of that reported for slcerotherapy. Variceal rebleeding in the sclerotherapy group required approximately 7 units of blood per episode. We concluded that immediate attempts at control of hemorrhage followed by portasystemic shunting remains the therapy of choice for these patients.

UR - http://www.scopus.com/inward/record.url?scp=0021906717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021906717&partnerID=8YFLogxK

M3 - Article

C2 - 3871605

AN - SCOPUS:0021906717

VL - 120

SP - 296

EP - 300

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 3

ER -